Logo image of PBTS

POWERBRIDGE TECHNOLOGIES CO (PBTS) Stock Fundamental Analysis

NASDAQ:PBTS - Nasdaq - KYG720071268 - Common Stock - Currency: USD

1.1  +0.08 (+7.32%)

After market: 1.1 0 (0%)

Fundamental Rating

1

Taking everything into account, PBTS scores 1 out of 10 in our fundamental rating. PBTS was compared to 284 industry peers in the Software industry. PBTS has a bad profitability rating. Also its financial health evaluation is rather negative. PBTS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PBTS has reported negative net income.
In the past 5 years PBTS reported 4 times negative net income.
In multiple years PBTS reported negative operating cash flow during the last 5 years.
PBTS Yearly Net Income VS EBIT VS OCF VS FCFPBTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 5M -5M -10M -15M -20M

1.2 Ratios

With a Return On Assets value of -34.89%, PBTS is not doing good in the industry: 73.74% of the companies in the same industry are doing better.
PBTS has a worse Return On Equity (-65.55%) than 67.27% of its industry peers.
Industry RankSector Rank
ROA -34.89%
ROE -65.55%
ROIC N/A
ROA(3y)-13.93%
ROA(5y)-14.32%
ROE(3y)-19.07%
ROE(5y)-43.18%
ROIC(3y)N/A
ROIC(5y)N/A
PBTS Yearly ROA, ROE, ROICPBTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 100 -100 200 300

1.3 Margins

PBTS has a worse Gross Margin (41.27%) than 73.38% of its industry peers.
PBTS's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for PBTS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.06%
GM growth 5Y-0.78%
PBTS Yearly Profit, Operating, Gross MarginsPBTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -50 -100 -150 -200

More info and screens

2

2. Health

2.1 Basic Checks

PBTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
PBTS has more shares outstanding than it did 1 year ago.
The debt/assets ratio for PBTS is higher compared to a year ago.
PBTS Yearly Shares OutstandingPBTS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M
PBTS Yearly Total Debt VS Total AssetsPBTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

PBTS has an Altman-Z score of -1.14. This is a bad value and indicates that PBTS is not financially healthy and even has some risk of bankruptcy.
PBTS's Altman-Z score of -1.14 is on the low side compared to the rest of the industry. PBTS is outperformed by 77.70% of its industry peers.
PBTS has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
PBTS's Debt to Equity ratio of 0.10 is in line compared to the rest of the industry. PBTS outperforms 53.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z -1.14
ROIC/WACCN/A
WACC6.21%
PBTS Yearly LT Debt VS Equity VS FCFPBTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 20M 40M 60M 80M 100M

2.3 Liquidity

PBTS has a Current Ratio of 1.07. This is a normal value and indicates that PBTS is financially healthy and should not expect problems in meeting its short term obligations.
PBTS has a Current ratio of 1.07. This is in the lower half of the industry: PBTS underperforms 74.82% of its industry peers.
PBTS has a Quick Ratio of 1.07. This is a normal value and indicates that PBTS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.07, PBTS is doing worse than 72.66% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 1.07
PBTS Yearly Current Assets VS Current LiabilitesPBTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

More info and screens

0

3. Growth

3.1 Past

PBTS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -496.21%.
Looking at the last year, PBTS shows a very negative growth in Revenue. The Revenue has decreased by -60.56% in the last year.
The Revenue for PBTS have been decreasing by -13.49% on average. This is quite bad
EPS 1Y (TTM)-496.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-457.95%
Revenue 1Y (TTM)-60.56%
Revenue growth 3Y-19.51%
Revenue growth 5Y-13.49%
Sales Q2Q%-6.2%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PBTS Yearly Revenue VS EstimatesPBTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M
PBTS Yearly EPS VS EstimatesPBTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 0 5 -5 -10 -15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PBTS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PBTS Price Earnings VS Forward Price EarningsPBTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PBTS Per share dataPBTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PBTS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

POWERBRIDGE TECHNOLOGIES CO

NASDAQ:PBTS (1/29/2024, 8:27:35 PM)

After market: 1.1 0 (0%)

1.1

+0.08 (+7.32%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)12-29 2022-12-29/amc
Inst Owners7.93%
Inst Owner Change-68.68%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.14M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.51
P/FCF N/A
P/OCF N/A
P/B 0.05
P/tB 0.08
EV/EBITDA N/A
EPS(TTM)-22.48
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.15
BVpS23.02
TBVpS13.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -34.89%
ROE -65.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.27%
FCFM N/A
ROA(3y)-13.93%
ROA(5y)-14.32%
ROE(3y)-19.07%
ROE(5y)-43.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.06%
GM growth 5Y-0.78%
F-ScoreN/A
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.07
Quick Ratio 1.07
Altman-Z -1.14
F-ScoreN/A
WACC6.21%
ROIC/WACCN/A
Cap/Depr(3y)177.66%
Cap/Depr(5y)235.15%
Cap/Sales(3y)19.41%
Cap/Sales(5y)16.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-496.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-457.95%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-60.56%
Revenue growth 3Y-19.51%
Revenue growth 5Y-13.49%
Sales Q2Q%-6.2%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-178.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y7.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.02%
OCF growth 3YN/A
OCF growth 5YN/A